See up to 3 months of AEON. The 7-day demo opens the 1M and 3M ranges and puts AEON on your watchlist.
Start 7-day demoLatest AEON insider trades
About AEON Biopharma, Inc. (AEON)
The SEC lists AEON Biopharma, Inc. under CIK 0001837607, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector. A registration statement was filed on 8 July 2026. No offering has priced.
AEON Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 1,150,000 | $243K |
AEON insider transactions (Form 4)
1613 Form 4 filings on record, the earliest from May 21, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Timothy P. Lynch - 10% Owner | Open-market purchase | Class A Common Stock | 1,150,000 | $0.21 footnote F1 | $243K | |
| ||||||
| Shelley B. Thunen - Director | Grant or award | Class A Common Stock | 222,684 | $0.00 footnote F1 | - | |
| ||||||
| Robert J. Palmisano - Director | Grant or award | Class A Common Stock | 222,684 | $0.00 footnote F1 | - | |
| ||||||
| Grant or award | Class A Common Stock | 222,684 | $0.00 footnote F1 | - | ||
| ||||||
| Grant or award | Class A Common Stock | 222,684 | $0.00 footnote F1 | - | ||
| ||||||
| Grant or award | Class A Common Stock | 222,684 | $0.00 footnote F1 | - | ||
| ||||||
| John Bencich - Officer | Grant or award | Class A Common Stock | 754,717 | $0.00 footnote F1 | - | |
| ||||||
| Chad Oh - Officer | Grant or award | Class A Common Stock | 862,500 | $0.00 footnote F1 | - | |
| Chad Oh - Officer | Grant or award | Class A Common Stock | 1,316,872 | $0.00 footnote F2 | - | |
| ||||||
| Alexander Blair Wilson - Officer | Grant or award | Class A Common Stock | 862,500 | $0.00 footnote F1 | - | |
| Alexander Blair Wilson - Officer | Grant or award | Class A Common Stock | 1,316,872 | $0.00 footnote F2 | - | |
| ||||||
| Jennifer Sy - Officer | Grant or award | Class A Common Stock | 575,000 | $0.00 footnote F1 | - | |
| Jennifer Sy - Officer | Grant or award | Class A Common Stock | 925,925 | $0.00 footnote F2 | - | |
| ||||||
| Robert E. Bancroft - Officer | Grant or award | Class A Common Stock | 3,000,000 | $0.00 footnote F1 | - | |
| ||||||
| Shelley B. Thunen | Grant or award | Restricted Stock Units | 308,641 | $0.00 | - | |
| Robert J. Palmisano | Grant or award | Restricted Stock Units | 308,641 | $0.00 | - | |
AEON insider trading FAQ
What is the latest insider trade for AEON?
AEON Biopharma, Inc. (AEON) had 1 insider filing in the last 90 days, with the most recent on 2026-08-21. The full record for AEON runs to 13 Form 4 filings, the earliest from 2025-05-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AEON stock?
1 insider purchase of AEON was filed in the last 90 days, totaling $243K.
How many insiders are selling AEON stock?
No insider sales of AEON were filed in the last 90 days.
Where can I see AEON SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AEON Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Timothy P. Lynch view on EDGAR
- - Shelley B. Thunen view on EDGAR
- - Robert J. Palmisano view on EDGAR
- - Marc Forth view on EDGAR
- - Jost Fischer view on EDGAR
- - Eric G. Carter view on EDGAR
- - John Bencich view on EDGAR
- - Chad Oh view on EDGAR
- - Alexander Blair Wilson view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where AEON's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AEON with a 7-day demo
- AEON on your watchlist
- Every AEON Form 4 filing on record
- Up to 3 months of AEON price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive